Analysis of Biobank data shows 1 in 8 adults may have NASH

  • April 15, 2018

UK Biobank is a major national and international health resource, and a registered charity in its own right. UK Biobank's aim is to improve the prevention, diagnosis and treatment of a wide range of serious and life-threatening illnesses.  A study by Perspectum Diagnostics using UK Biobank data has revealed that the prevalence of non-alcoholic steatohepatitis (NASH) among UK adults could be as high as 12%.1 NASH is a progressive form of non-alcoholic fatty liver disease (NAFLD) which is now considered to be one of the major causes of cirrhosis of the liver.

Read the full post on the UK Biobank Data website.